Literature DB >> 15187491

National Kidney Disease Education Program in 2004: a program in evolution.

Thomas Hostetter, Elisa H Gladstone, Domenic A Sica.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15187491      PMCID： PMC8109720          DOI： 10.1111/j.1524-6175.2004.03697.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  15 in total

1.  The national high blood pressure education program: thirty years and counting.

Authors:  Daniel W Jones; John E Hall
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

2.  USRDS: the United States Renal Data System.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

3.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

4.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function.

Authors:  B L Kasiske; J D Lakatua; J Z Ma; T A Louis
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860
View more
  1 in total

1.  Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey.

Authors:  Oliver Lenz; Alessia Fornoni
Journal:  BMC Med       Date:  2006-12-12       Impact factor: 8.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.